Основные публикации по теме НИР 0341-2016-0002

«Трансляционные исследования молекулярных механизмов патогенеза органной недостаточности»

1. A method for microencapsulation of cells and a device for its realization. Lepekhova Sa., Goldberg Oa., Kravchenko Aa., Batraks Ae., Koval Ev., Kurgansky Is., Apartsin Ka.Bulletin of Experimental Biology and Medicine. 2017. Т. 162. № 6. С. 820-823.

2. The level of free circulating mitochondrial DNA in blood as predictor of death in case of acute coronary syndrome. Sudakov N.P., Apartsin K.A., Lepekhova S.A., Nikiforov S.B., Katyshev A.I., Lifshits G.I., Vybivantseva A.V., Konstantinov Yu.M. European journal of medical research. 2017. Т. 22.
№ 1.

3. CYP2C19 polymorphism frequency in russian patients in Central Russia and Siberia with acute coronary syndrome. Mirzaev, Karin B.; Zelenskaya, Elena M.; Barbarash, Olga L.; Apartsin K.A., Lifshits G.I. и др. Pharmacogenomics & personalized medicine. Том: 10  Стр.: 107-114

4. Разработка способа патоморфологической оценки давности развития инфаркта миокарда. Шурыгина И.А., Каня О.В., Дремина Н.Н., Шурыгин М.Г. Современные технологии в медицине. 2017. Т. 9. № 2. С. 126-130.

5. Comparison of fatal or irreversible events with extended‐duration betrixaban versus standard dose enoxaparin in acutely ill medical patients: an apex trial substudy. Gibson C.M., Korjian S., Chi G., Daaboul Ya., Jain P., Arbetter D., Goldhaber S.Z., Hull R., Hernandez A.F., Lopes R.D., Gold A., Cohen A.T., Harrington R.A., Nikolaev K., Apartsin Ka.

Journal of the American Heart Association. 2017. Т. 6. № 7. С. e006015.

6. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial Aksentyev S, Apartsin K, ..,  Morrow DA;  LATITUDE-TIMI 60 Investigators.//JAMA. 2016 Apr 19;315 (15):1591-9.

7. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients  (статья) / Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators и др., всего 287 чел. //N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 .- May 27. – р. 534-544.

9. V.L. Mikhailenko, V.N. Kizhnyaev, S.I. Verkhoturova, K.A. Apartsin, N.K. Gusarova,  E.G. Grigor’ev, B.A. Trofimov Synthesis and Properties of a New Family of Phosphorus and Nitrogen Containing oneness Doklady Akademii Nauk, 2015, Vol. 465, No. 4, pp. 446–450.

8. Comparison of Fondaparinux with Low-Molecular-Weight Heparin for Venous Thromboembolism Prevention in Patients Requiring Rigid or Semi-Rigid Immobilization for Isolated Non-Surgical Below-Knee Injury / Samama C.M.,  Lecoules N., Kierzek G., Claessens Y.E., Riou B., Rosencher N., Mismetti P., Sautet A.,Barrellier M.-T., Apartsin K., Jonas M., Caeiro J.R., Van der veen A.H., Roy P.-M., Groupe FONDACAST // Ann. Fr. Med. Urgence (2014) 4:153-166.DOI 10.1007/s13341-014-0405-z.- 153-156.

10. Sharing Data from Cardiovascular Clinical Trials--A Proposal (статья) /Academic Research Organization Con-sortium for Con-tinuing Evaluation of Scientific Stud-ies--Cardiovascular (ACCESS CV). Patel MR, Armstrong PW, Bhatt DL, Braunwald E, Camm A, Fox KA,  и др., всего 183 чел. //N Engl J Med. 2016 Aug 4;375(5):407-9.

  

WoS Researcher ID, Scopus Author ID руководителя и основных исполнителей:

Апарцин К.А. WoS Researcher ID B -9179-2017 ;Scopus Author ID - 65069998669

Лифшиц Г.И. WoS Researcher ID — Q-3500-2016. Scopus Author ID –55971670400

Лепехова С.А. Scopus Author ID – 55324172700